Manipulation of a spider peptide toxin alters its affinity for lipid bilayers and potency and selectivity for voltage-gated sodium channel subtype 1.7.

disulfide-rich peptides drug design electrophysiology ion channel pain peptide interaction peptide–lipid membrane regioselective oxidation toxin tri-molecular complex

Journal

The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R

Informations de publication

Date de publication:
10 04 2020
Historique:
received: 11 12 2019
revised: 03 03 2020
pubmed: 7 3 2020
medline: 15 12 2020
entrez: 7 3 2020
Statut: ppublish

Résumé

Huwentoxin-IV (HwTx-IV) is a gating modifier peptide toxin from spiders that has weak affinity for the lipid bilayer. As some gating modifier toxins have affinity for model lipid bilayers, a tripartite relationship among gating modifier toxins, voltage-gated ion channels, and the lipid membrane surrounding the channels has been proposed. We previously designed an HwTx-IV analogue (gHwTx-IV) with reduced negative charge and increased hydrophobic surface profile, which displays increased lipid bilayer affinity and

Identifiants

pubmed: 32139508
pii: S0021-9258(17)48599-1
doi: 10.1074/jbc.RA119.012281
pmc: PMC7152767
doi:

Substances chimiques

Lipid Bilayers 0
NAV1.7 Voltage-Gated Sodium Channel 0
Peptide Fragments 0
Scorpion Venoms 0
Spider Venoms 0

Banques de données

PDB
['5TLR']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5067-5080

Références

Toxicon. 2008 Feb;51(2):230-9
pubmed: 18054060
Mol Pain. 2012 Mar 22;8:17
pubmed: 22439790
J Biol Chem. 2011 Jul 8;286(27):24231-41
pubmed: 21576247
Cardiovasc Ther. 2010 Oct;28(5):287-94
pubmed: 20645984
Peptides. 2015 Jun;68:148-56
pubmed: 25218973
ACS Chem Biol. 2017 Sep 15;12(9):2324-2334
pubmed: 28741926
Br J Pharmacol. 2017 Aug;174(15):2528-2544
pubmed: 28542706
Nat Rev Neurosci. 2015 Sep;16(9):511-9
pubmed: 26243570
Neuron. 2000 Apr;26(1):13-25
pubmed: 10798388
Pain. 2014 Oct;155(10):1962-75
pubmed: 24972070
J Biol Chem. 2018 Jun 8;293(23):9041-9052
pubmed: 29703751
J Biol Chem. 2020 Jan 31;295(5):1315-1327
pubmed: 31871053
J Med Chem. 2015 Sep 24;58(18):7093-118
pubmed: 25927480
J Biol Chem. 2013 Aug 2;288(31):22707-20
pubmed: 23760503
PLoS One. 2018 May 3;13(5):e0196791
pubmed: 29723257
Biochim Biophys Acta. 2016 Apr;1858(4):872-82
pubmed: 26850736
Neuropharmacology. 2017 Dec;127:32-45
pubmed: 28400258
Trends Neurosci. 2007 Nov;30(11):555-63
pubmed: 17950472
Pain. 2019 Aug;160(8):1766-1780
pubmed: 31335646
Biochim Biophys Acta Biomembr. 2017 May;1859(5):835-844
pubmed: 28115115
Pharmacol Ther. 2017 Apr;172:73-100
pubmed: 27916648
Proc Natl Acad Sci U S A. 2012 Nov 20;109(47):19444-9
pubmed: 23115331
J Gen Physiol. 2007 Nov;130(5):497-511
pubmed: 17938232
Nature. 2004 Jul 8;430(6996):235-40
pubmed: 15241420
Cell. 2019 Feb 7;176(4):702-715.e14
pubmed: 30661758
Nature. 2004 Jul 8;430(6996):232-5
pubmed: 15241419
Neurosci Lett. 2018 Jul 13;679:35-47
pubmed: 29684532
Neurology. 2016 Jan 12;86(2):161-9
pubmed: 26659129
Brain. 2005 Aug;128(Pt 8):1847-54
pubmed: 15958509
J Biol Chem. 2019 Aug 2;294(31):11892-11909
pubmed: 31201274
Nature. 2016 Jun 06;534(7608):494-9
pubmed: 27281198
Cell Chem Biol. 2020 Mar 19;27(3):306-313.e4
pubmed: 31732432
Mol Pharmacol. 2008 Nov;74(5):1476-84
pubmed: 18728100
Mol Pharmacol. 2018 Nov;94(5):1256-1269
pubmed: 30135145
J Cell Sci. 2011 Jan 1;124(Pt 1):5-8
pubmed: 21172818
J Biol Chem. 2016 May 27;291(22):11829-42
pubmed: 27026701
Sci Rep. 2016 Sep 28;6:34333
pubmed: 27677715
Science. 2019 Mar 22;363(6433):1303-1308
pubmed: 30765606
PLoS One. 2017 Mar 16;12(3):e0173551
pubmed: 28301520
Biochim Biophys Acta. 2015 Nov;1848(11 Pt A):2767-78
pubmed: 26342676
J Biol Chem. 2005 Mar 25;280(12):11127-33
pubmed: 15632158
Curr Opin Pharmacol. 2008 Feb;8(1):50-6
pubmed: 17964852
Proc Natl Acad Sci U S A. 2014 Dec 16;111(50):E5463-70
pubmed: 25453087
PLoS One. 2016 Aug 24;11(8):e0161450
pubmed: 27556810
Mol Cell Neurosci. 1997;10(3-4):196-207
pubmed: 9532581
Toxins (Basel). 2017 Aug 12;9(8):
pubmed: 28805686
Toxins (Basel). 2016 Mar 17;8(3):
pubmed: 26999206
J Biol Chem. 2016 Aug 12;291(33):17049-65
pubmed: 27311819
ACS Chem Biol. 2013;8(6):1215-22
pubmed: 23527544
Trends Pharmacol Sci. 2010 Apr;31(4):175-82
pubmed: 20097434
Neuropharmacology. 2018 May 1;133:404-414
pubmed: 29474819
J Biol Chem. 2011 Aug 5;286(31):27301-10
pubmed: 21659528
Nat Genet. 2000 Apr;24(4):343-5
pubmed: 10742094
J Biol Chem. 2013 Jul 12;288(28):20392-403
pubmed: 23703613
Sci Rep. 2017 Jan 20;7:40883
pubmed: 28106092
Nat Struct Mol Biol. 2009 Oct;16(10):1080-5
pubmed: 19783984
Peptides. 2013 Jun;44:40-6
pubmed: 23523779
Neurology. 2002 Apr 9;58(7):1122-4
pubmed: 11940708
Nature. 2006 Dec 14;444(7121):894-8
pubmed: 17167479
J Biol Chem. 2008 Oct 3;283(40):27300-13
pubmed: 18628201
Neurology. 2019 Mar 26;92(13):e1405-e1415
pubmed: 30824560
Sci Rep. 2017 Jan 03;7:39662
pubmed: 28045073
J Med Chem. 2015 Mar 12;58(5):2299-314
pubmed: 25658507
Ann Neurol. 2009 Jun;65(6):733-41
pubmed: 19557861
Nat Rev Neurosci. 2013 Jan;14(1):49-62
pubmed: 23232607
Pain. 2018 Mar;159(3):469-480
pubmed: 29176367
Protein Sci. 1994 Oct;3(10):1833-9
pubmed: 7849598
Toxicon. 2013 Sep;71:57-65
pubmed: 23726857
J Neurosci. 2006 Dec 13;26(50):12852-60
pubmed: 17167076

Auteurs

Akello J Agwa (AJ)

Institute for Molecular Bioscience, Centre for Pain Research, The University of Queensland, Brisbane, Queensland 4072, Australia.

Poanna Tran (P)

Institute for Molecular Bioscience, Centre for Pain Research, The University of Queensland, Brisbane, Queensland 4072, Australia.

Alexander Mueller (A)

Institute for Molecular Bioscience, Centre for Pain Research, The University of Queensland, Brisbane, Queensland 4072, Australia.

Hue N T Tran (HNT)

Institute for Molecular Bioscience, Centre for Pain Research, The University of Queensland, Brisbane, Queensland 4072, Australia.

Jennifer R Deuis (JR)

Institute for Molecular Bioscience, Centre for Pain Research, The University of Queensland, Brisbane, Queensland 4072, Australia.

Mathilde R Israel (MR)

Institute for Molecular Bioscience, Centre for Pain Research, The University of Queensland, Brisbane, Queensland 4072, Australia.

Kirsten L McMahon (KL)

Institute for Molecular Bioscience, Centre for Pain Research, The University of Queensland, Brisbane, Queensland 4072, Australia.

David J Craik (DJ)

Institute for Molecular Bioscience, Centre for Pain Research, The University of Queensland, Brisbane, Queensland 4072, Australia.

Irina Vetter (I)

Institute for Molecular Bioscience, Centre for Pain Research, The University of Queensland, Brisbane, Queensland 4072, Australia.
School of Pharmacy, The University of Queensland, Woolloongabba, Queensland 4103, Australia.

Christina I Schroeder (CI)

Institute for Molecular Bioscience, Centre for Pain Research, The University of Queensland, Brisbane, Queensland 4072, Australia christina.schroeder@nih.gov.
National Cancer Institute, National Institutes of Health, Frederick, Maryland 21702, USA.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH